Abhishek Kumar: Next-Gen Insights on Antiphospholipid Syndrome Care
Abhishek Kumar, Lead Analyst at DelveInsight Business Research LLP, shared a post on LinkedIn:
“Next-Gen Antiphospholipid Syndrome Pipeline Insights Transforming Autoimmune Care
Antiphospholipid Syndrome is gaining attention as research shifts from symptom control to precision immunology. Scientists are exploring complement inhibition, B-cell modulation, and targeted biologics to reduce clot risk, inflammation, and pregnancy complications. Growing awareness, improved diagnostics, and expanding clinical trials are accelerating therapeutic innovation. The future of APS care may soon include disease-modifying treatments that address immune mechanisms rather than only preventing thrombosis. Discover how emerging science is reshaping autoimmune management and guiding next-generation treatment strategies for better long-term outcomes and patient quality of life.
Recent developments include, National Institute of Allergy and Infectious Diseases (NIAID) announced result of Targeting CD38 With Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI).
The Antiphospholipid Syndrome Companies include Genentech (Roche), Sanofi, Bristol Myers Squibb, Teva Pharmaceuticals, Pfizer, Novartis, and others.
Learn more about rare disease innovation and next-generation therapies today.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF
-
Oct 29, 2026, 14:59Jodi Neuhauser: We Need a Graveyard of Women’s Health Companies (In a Positive Way)
-
Oct 29, 2026, 14:56Resa Nabor: An Inspiring Story of Strength, Courage, and Never Giving Up
-
Oct 29, 2026, 14:54Robert Borowczyk: What Happens After a Failed IVF Cycle?
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
-
Oct 28, 2026, 15:37Gili Band: The People Are What Stay With Me After Day 1 at ASRM 2026